Inhibition of Metastases by Anticoagulants
Open Access
- 6 January 1999
- journal article
- review article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 91 (1), 22-36
- https://doi.org/10.1093/jnci/91.1.22
Abstract
Metastasis involves several distinct steps, including one in which the tumor cell, after entry into the bloodstream, comes to rest in a capillary located at the distant site where a metastatic tumor will ultimately form. Components of the blood-clotting pathway may contribute to metastasis by trapping cells in capillaries or by facilitating adherence of cells to capillary walls. Conceivably, anticoagulants could interfere with this step in the metastatic process. In this review, we have summarized current knowledge on the interaction of malignant cells, clotting factors, and anticoagulants. We used computerized (MEDLINE®) and manual searches to identify studies done in humans, in animals, and in in vitro systems that were published in English between 1952 and 1998. We found many reports that the formation of metastatic tumors could be inhibited by heparin, a vitamin K antagonist (warfarin), and inhibitors of platelet aggregation (prostacyclin and dipyridamole). Despite these encouraging preliminary results and a compelling biochemical rationale, only limited information exists on the clinical use of anticoagulants for the prevention or treatment of metastatic cancer because there have been so few controlled and prospectively randomized studies on this topic. In view of the preliminary results, anticoagulants may hold promise for the prevention and treatment of metastases. We believe that larger controlled investigations are strongly warranted to evaluate the clinical potential of anticoagulants for the prevention and treatment of metastases in humans.Keywords
This publication has 110 references indexed in Scilit:
- Antimetastatic action of the prostacyclin analogue cicaprost in experimental mammary tumorsBreast Cancer Research and Treatment, 1996
- The prostacyclin analogue cicaprost inhibits metastasis of tumours of R 3327 MAT Lu prostate carcinoma and SMT 2A mammary carcinomaZeitschrift für Krebsforschung und Klinische Onkologie, 1992
- Dipyridamole enhances an anti‐proliferative effect of interferon in various types of human tumor cellsInternational Journal of Cancer, 1992
- Dipyridamole combination chemotherapy can be used safely in treating gastric cancer patientsAnti-Cancer Drugs, 1991
- The first international urokinase/warfarin trial in colorectal cancerClinical & Experimental Metastasis, 1991
- Tumors: Wounds That Do Not HealNew England Journal of Medicine, 1986
- Effects of EGF and thrombin on inositol‐containing phospholipids of cultured fibroblasts: Stimulation of phosphatidylinositol synthesis by thrombin but not EGFJournal of Cellular Physiology, 1985
- 9-Deoxy-Δ9-prostaglandin D2, a prostaglandin D2 derivative with potent antineoplastic and weak smooth muscle-contracting activitiesBiochemical and Biophysical Research Communications, 1982
- Antimetastatic effects associated with platelet reduction.Proceedings of the National Academy of Sciences, 1968
- Radioautography of in vitro labeled tumor cells in postoperative wound drainageCancer, 1966